However, F. prausnitzii has been shown to produce butyrate resulting in an anti-inflammatory role by inhibiting interleukin (IL-6), the activator of transcription 3 (STAT3)/IL-17 pathway in colorectal colitis having an important role in inflammatory bowel disease (IBD) treatment [35]. Here, IL17A is linked to inflammatory bowel disease.